Stem-cell therapy has promise in the treatment of high-risk type 1 diabetes. A clinical study presented at ENDO 2022, the Endocrine Society's annual meeting in Atlanta, Georgia, suggests that an investigational stem cell-based therapy called PEC-Direct, inten…